Conformational spaces of Cinchona alkaloids

Chirality

Volumn 15, Issue 7, 2003, Pages 637-645

  Caner, Hava ^a   Biedermann, P Ulrich ^a   Agranat, Israel ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Epiquinidine; Epiquinine; Quasienantiomers; Quinidine; Quinine; Semiempirical study

Indexed keywords

CINCHONA ALKALOID; CINCHONIDINE; CINCHONINE; EPICINCHONIDINE; EPICINCHONINE; EPIQUINIDINE; EPIQUININE; QUINIDINE; QUININE; UNCLASSIFIED DRUG;

ARTICLE; CINCHONA; DRUG CONFORMATION; ENANTIOMER; ENERGY; EPIMER; HYDROGEN BOND; PRIORITY JOURNAL;

CINCHONA ALKALOIDS; MOLECULAR CONFORMATION;

EID: 0041663651     PISSN: 08990042     EISSN: None     Source Type: Journal    
DOI: 10.1002/chir.10265     Document Type: Article

References (46)

1. Honigsbaum M. The fever trail. The hunt for the cure for malaria. London: Macmillan; 2001. p 30.
2. McGrew RE. Encyclopedia of medicinal history. New York: McGraw-Hill; 1985. p 166.
3. The World Health Organization (WHO) Report 2002. Reducing risk, promoting healthy life. Annex Table 2. Deaths by cause, sex and mortality stratum in WHO regions, estimates for 2001. p 186-191.
4. Wahlgren M, Perlmann P. Eds. Malaria. Molecular and clinical aspects. New York: Harwood Academic Publishers; 1999.
5. Nosten F, McGready R. In: Duffy PE, Fried M, editors. Malaria in pregnancy. London: Taylor and Francis; 2001. p 223.
6. Tracy JW, Webster LT Jr. Drugs used in the chemotherapy of protozoal infections. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A. editors. Goodman and Gilmans - the pharmacological basis of therapeutics, 10th ed. New York: McGraw Hill; 2002. p 965-985.
7. Wernsdorfer WH, McGregor I (eds.). Malaria - principles and practice of malariology. London: Churchill Livingstone; 1988.
8. Dollery C (ed.). Therapeutic drugs, 2nd ed. London: Churchill Livingstone; 1999. p Q10-Q21.
9. Hiemstra H, Wynberg H. Addition of aromatic thiols to conjugated cycloalkenones, catalyzed by chiral β-hydroxy amines. A mechanistic study on homogeneous catalytic asymmetric synthesis. J Am Chem Soc 1981;103:417-430.
10. Wynberg H. Asymmetric catalysis by alkaloids. Top Stereochem 1986;16:87-129.
11. Lammerhofer M, Lindner W. Quinine and quinidine derivatives as chiral selectors. 1. Brush type chiral stationary phases for high-performance liquid chromatography based on cinchonan carbamates and their application as chiral anion exchangers. J Chromatogr A 1996;741:33-48.
12. Schefzick S, Lindner W, Lipkowitz KB, Jalaie M. Enantiodiscrimination by a quinine-based chiral stationary phase: A computational study. Chirality 2000;12:7-15.
13. Aune M, Googoll A, Matsson O. Solvent dependence of enantioselectivity for a base-catalyzed 1,3-hydron transfer-reaction - a kinetic isotope effect and NMR spectroscopic study. J Org Chem 1995;60:1356-1364.
14. Norrby PO, Kolb HC, Sharpless KB. Toward an understanding of the high enantioselectivity in the osmium-catalyzed asymmetric dihydroxylation. 2. A qualitative molecular mechanics approach. J Am Chem Soc 1994;116:8470-8478.
15. Lohray BB. Recent advances in the asymmetric dihydroxylation of alkenes. Tetrahadron Asymmetry 1992;3:1317-1349.
16. Eliel EL, Wilen SH, Mander LN. Stereochemistry of organic compounds. New York: John Wiley & Sons; 1994. p 866.
17. Woodword RB, Cava MP, Ollis WD, Hunger A, Daenika HU, Schenker K. The total synthesis of strychnine. Tetrahedron 1963;19:247-288.
18. Jacques J, Collet A, Wilen S. Enantiomers, racemates and resolution. New York: Wiley Interscience; 1981.
19. Oleksyn BJ, Lebioda L. Configuration-conformation relationship in cinchona alkaloids. Polish J Chem 1980;54:755.
20. Dijkstra GDH, Kellogg RM, Wynberg H. Conformational-analysis of some chiral catalysts of the cinchona and ephedra family. The alakloid catalyzed addition of aromatic thiols to cyclic α,β-unsaturated ketons. Recl Trav Chim Pays-Bas 1989;108:195-204.
21. Dijkstra GDH, Kellogg RM, Wynberg H, Svendsen JS, Marko I, Sharpless KB. Conformational study of cinchona alkaloids. A combined NMR, molecular mechanics, and X-ray approach. J Am Chem Soc 1989;111:8069-8076.
22. Uccello-Barretta G, Di Bari L, Salvadori P. Autoaggregation phenomena in quinine solutions. Magn Reson Chem 1992;30:1054-1063.
23. Cheklov AN, Kaluski Z, Struckov YT, Malusinska G, Kitajgorodskij AN. Crystal structure and absolute configuration (+)-10-bromo-10,11-dihydroepiquinidine. Zhurn Strukt Khim 1974;15:886-891.
24. Doherty R, Benson WR, Maienthal M, Stewart JM. Crystal and molecular structure of quinidine. J Pharm Sci 1978;67:1698-1701.
25. Oleksyn BJ, Lebioda L, Ciechanowicz-Rutkowska M. Molecular and crystal structure of the alkaloid cinchonine. Acta Cryst 1979;B35:440-444.
26. Oleksyn BJ. The alkaloid cinchonidine. Acta Cryst 1982;B38:1832-1834.
27. 2. Acta Cryst 1983;C39:310-312.
28. Pniewska B, Suszko-Purzycka A. Structure of quinine monohydrate toluene solvate. Acta Cryst 1989;C45:638-642.
29. Karle JM, Karle IL. Structure of 9-epiquinine hydrochloride dihyrate versus antimalarial activity. Acta Cryst 1992;C48:1975-1980.
30. Karle JM, Karle IL, Gerena L, Milhous WK. Stereochemical evaluation of the relative activities of the cinchona alkaloids against plasmodium-falciparum. Antimicrob Agents Chemo 1992;36:1538-1544.
31. Kowalik JT, Lipinska T, Oleksyn BJ, Sliwinski J. Conformation of epicinchonine and cinchonine in view of their antimalarial activity: X-ray and theoretical studies. Enantiomer 1999;4:389-410.
32. Oleksyn BJ, Suszko-Purzycka A, Dive G, Lamotte-Brasseur J. Molecular-properties of cinchona alkaloids - a theoretical approach. J Pharm Sci 1992;81:122-127.
33. 3 catalyst. Kinetic evidence for the substrate-modifier interaction in the liquid phase. Tetrahedron Asymmetry 1996;7:571-580.
34. Silva THA, Oliveira AB, De Almeida WB. Conformational analysis of the antimalarial agent quinine. Struct Chem 1997;8:95-107.
35. Silva THA, Oliveira AB, De Almeida WB. Conformational analysis of the antimalarial agent quinidine. Bioorgan Med Chem 1997;5:353-361.
36. Aranda DAG, Carneiro JWM, Oliveira CSB, Passos FB, Souza PRN, Antunes OAC. A semiempirical study of the conformational behavior of cinchonidine and its interaction with methyl pyruvate. Braz J Chem Eng 2001;18:287-298.
37. Bürgi T, Baiker A. Conformational behavior of cinchonidine in different solvents: a combined NMR and ab initio investigation. J Am Chem Soc 1998;120:12920-12926.
38. Silva THA, Oliveira AB, Dos Santos HF, De Almeida WB. Conformational analysis of epiquinine and epiquinidine. Struct Chem 2001;12:431-437.
39. Prelog V, Wilhelm M. Untersuchungen uber asymmetrische Synthesen VI). Der Reaktionsmechanismus und der sterische verlauf der asymmetrischen Cyanhydrin-synthese. Helv Chem Acta 1954;37:1634-1660.
40. Berg U, Aune M, Matsson O. Dihydroquinidine conformation revisited - Variable temprature NMR and CD spectroscopy, and molecular mechanics computations. Tetrahedron Lett 1995;36:2137-2140.
41. A preliminary report of this study was presented: Caner H, Biedermann PU, Agranat I. The conformational spaces of cinchona alkaloids. A semiempirical study. Book of Abstracts, 12th International Symposium on Chiral Discrimination (ISCD12-Chirality 2000), Chamonix Mont-Blanc 24-28 September 2000, J-2.
42. (a) Stewart JJP. Optimization of parameters for semiempirical methods I. Method J Comput Chem 1989;10:209-220.
43. (b) Stewart JJP. Optimization of parameters for semiempirical methods II. Applications. J Comput Chem 1989;10:221-264.
44. (a) Stewart JJP. MOPAC - a semiempirical molecular orbital program. J Comput Aid Molec Des 1990;4:1-45.
45. (b) Stewart JJP. MOPAC 93: a general molecular orbital package. Tokyo, Japan: Fujitsu Limited; 1993 QCPE program no. 689.
46. Stewart JJP. MOPAC 93.00 manual. Tokyo, Japan: Fujitsu Limited; 1993.